INNOVENTRIC is based in Rehovot, Israel. It has raised $41M in total funding. Latest round: Series B.
INNOVENTRIC funding overview
INNOVENTRIC is based in Rehovot, Israel. INNOVENTRIC has raised $41M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in October 2024. The round record for INNOVENTRIC runs through 2024; nothing later has been disclosed. Investors on record include RA Capital Management, European Innovation Council (EIC) Fund, BRM Group, JG Private Equity, Mivtach Shamir Holdings, Agate JT Healthcare Fund and 1 others. 7 distinct backers are named across the disclosed rounds.
INNOVENTRIC at a glance
Total raised
$41M
Latest round
Series B
Latest round date
October 2024
Headquarters
Rehovot, Israel
Notable investors
RA Capital Management, European Innovation Council (EIC) Fund, BRM Group, JG Private Equity, Mivtach Shamir Holdings, Agate JT Healthcare Fund, Prof. Benad Goldwasser
Frequently asked about INNOVENTRIC funding
How much has INNOVENTRIC raised?
INNOVENTRIC has raised $41M in total disclosed funding across the rounds on record.
Who has invested in INNOVENTRIC?
RA Capital Management, European Innovation Council (EIC) Fund, BRM Group, JG Private Equity, Mivtach Shamir Holdings, Agate JT Healthcare Fund are named among the investors backing INNOVENTRIC.
What was the latest INNOVENTRIC funding round?
The most recent disclosed round is a Series B, announced in October 2024.
Where is INNOVENTRIC based?
INNOVENTRIC is based in Rehovot, Israel.
When did INNOVENTRIC last raise?
The last disclosed INNOVENTRIC round closed in October 2024 at Series B.
Totals shown for INNOVENTRIC aggregate every disclosed round on file. To see how that compares, browse the companies in Rehovot and the investors behind them below.
